Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,501–5,525 of 7,816 matching trials · page 221 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
CHOICE Plus Program: Supporting Relationship-centred Mealtimes for Long-term Care NCT03634774 CHOICE+ Training Program Runs in: Canada · 3 sites |
NA other |
COMPLETED | 153 | University of Waterloo OTHER |
2019-12-20 |
|
BIIB092 in Primary Tauopathies: CBS, nfvPPA, sMAPT, and TES NCT03658135 BIIB092; Placebo Runs in: United States · 1 site |
PHASE1 other |
TERMINATED | 22 | University of California, San Francisco OTHER |
2019-12-19 |
|
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal Dementia NCT00613119 Runs in: United States · 1 site |
NA other |
COMPLETED | 108 | National Institute of Mental Health (NIMH) NIH |
2019-12-16 |
|
Mild Neurocognitive Disorder in HIV Infection of the Brain NCT01547754 Runs in: United States · 1 site |
NA other |
TERMINATED | 8 | National Institute of Mental Health (NIMH) NIH |
2019-12-16 |
|
Impact of a Mediator for Patient Intake in Emergency Departments NCT03139110 Presence of a mediator in the emergency departments Runs in: France · 4 sites |
NA other |
COMPLETED | 2,378 | Hospices Civils de Lyon OTHER |
2019-12-16 |
|
Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian Disorders NCT00001178 Runs in: United States · 1 site |
NA other |
TERMINATED | 597 | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
2019-12-12 |
|
Imaging Studies of Cognitive Impairment in Parkinson s Disease NCT01862744 Runs in: United States · 1 site |
NA other |
COMPLETED | 76 | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
2019-12-12 |
|
Early Markers of Alzheimer's Disease: Structural and Functional Brain Changes NCT01867372 Runs in: United States · 3 sites |
NA other |
TERMINATED | 213 | National Institute on Aging (NIA) NIH |
2019-12-12 |
|
Focused Cognitive Testing in Inpatients NCT02826473 BRAINCHECK Runs in: Switzerland · 1 site |
NA other |
TERMINATED | 150 | Luzerner Kantonsspital OTHER |
2019-12-12 |
|
Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease NCT00299988 Intravenous Immunoglobulin; Placebo Runs in: United States · 1 site |
PHASE2 other |
TERMINATED | 24 | Weill Medical College of Cornell University OTHER |
2019-12-11 |
|
End-of-life Intervention for African American Dementia Caregivers NCT03323411 Advance Care Treatment Plan |
NA other |
COMPLETED | 355 | University of Illinois at Chicago OTHER |
2019-12-10 |
|
Brain Tissue Collection for Neuropathological Studies NCT00001260 Runs in: United States · 3 sites |
NA other |
TERMINATED | 2,161 | National Institute of Mental Health (NIMH) NIH |
2019-12-09 |
|
Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations NCT02676843 18F-AV-1451 Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 7 | Columbia University OTHER |
2019-12-06 |
|
Pilot Study to Assess the Impact of a Mobile Health Application (App) on Clinical Outcomes and Satisfaction of Older HIV-Infected Patients, as an Emerging Tool for Care, Education and Prevention. NCT04137016 Mobile application Runs in: Spain · 1 site |
NA other |
COMPLETED | 100 | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia OTHER |
2019-12-06 |
|
The Dementia Symptom Management at Home Program Hospice Edition NCT03352791 DSM-H Hospice Edition performance improvement program; Usual Care Runs in: United States · 1 site |
NA other |
TERMINATED | 2 | NYU Langone Health OTHER |
2019-12-04 |
|
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease NCT02245737 Lanabecestat; Placebo Runs in: Australia; Belgium; Canada; France; Germany; Hungary; Ita... · 254 sites |
PHASE2|PHASE3 BACE-inhibitor |
TERMINATED | 2,218 | AstraZeneca INDUSTRY |
2019-12-03 |
|
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia NCT02783573 Lanabecestat; Placebo Runs in: Canada; China; Czechia; Denmark; France; Germany; Italy; ... · 262 sites |
PHASE3 BACE-inhibitor |
TERMINATED | 1,722 | AstraZeneca INDUSTRY |
2019-12-03 |
|
A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia NCT02972658 Lanabecestat Runs in: Australia; Belgium; Canada; France; Germany; Hungary; Jap... · 133 sites |
PHASE3 BACE-inhibitor |
TERMINATED | 421 | AstraZeneca INDUSTRY |
2019-12-03 |
|
A Study to Determine the Metabolism and Elimination of [14C]E2027 in Healthy Male Participants NCT04023877 E2027 Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 8 | Eisai Inc. INDUSTRY |
2019-12-03 |
|
Photo Neuro-Modulation Therapy to Adults NCT04182529 Photoneuromodulation therapy; Sham Runs in: Hong Kong · 1 site |
NA other |
UNKNOWN | 40 | Chinese University of Hong Kong OTHER |
2019-12-02 |
|
Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's Disease NCT02388152 Lu AF20513, low dose; Lu AF20513, medium dose; Lu AF20513, high dos... Runs in: Austria; Finland; Sweden · 5 sites |
PHASE1 other |
TERMINATED | 50 | H. Lundbeck A/S INDUSTRY |
2019-11-29 |
|
Reference Database & Longitudinal Registry of the Normal and Pathological Aging Brain NCT02875496 Runs in: United States · 1 site |
NA other |
UNKNOWN | 2,000 | ElMindA Ltd INDUSTRY |
2019-11-27 |
|
Single Bolus Dose of Ketodex Versus Ketofol For Prevention Of Emergence Agitation In Adults Undergoing Nasal Surgeries NCT04018157 "Ketamine" and "dexmedetomidine" and "propofol" and "0.9%saline" Runs in: Egypt · 1 site |
EARLY_PHASE1 other |
COMPLETED | 150 | Zagazig University OTHER_GOV |
2019-11-27 |
|
Cancer Distress Coach Mobile App Trial NCT02986152 Cancer Distress Coach Mobile App Runs in: United States · 1 site |
NA other |
COMPLETED | 569 | Duke University OTHER |
2019-11-26 |
|
P-glycoprotein Function in Brain Diseases NCT00677885 Runs in: United States · 1 site |
NA other |
COMPLETED | 20 | National Institute of Mental Health (NIMH) NIH |
2019-11-22 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial